期刊文献+

逍遥五苓散联合马来酸曲美布汀胶囊治疗腹泻型肠易激综合征44例临床观察 被引量:4

Observation on treating IBS of diarrhea type with Xiaoyao Wuling San plus trimebutine maleate capsule
下载PDF
导出
摘要 目的:观察逍遥五苓散联合马来酸曲美布汀胶囊治疗腹泻型肠易激综合征的临床疗效。方法:将80例腹泻型IBS患者随机分为治疗组44例和对照组36例。对照组给予马来酸曲美布汀胶囊每次0.2g,每日3次,饭前30min口服。治疗组在对照组基础上加逍遥五苓散煎剂,两日一剂,饭后服用。两组患者均治疗4周后观察临床疗效,并比较两组治疗前后中医症状(腹痛,腹泻次数,大便形状,粘液便)积分。结果:治疗组临床疗效总有效率为95.45%,对照组为86.11%,两组比较差异有统计学意义(P<0.05)。结论:逍遥五苓散联合马来酸曲美布汀胶囊治疗腹泻型IBS患者可明显改善临床症状,提高临床疗效,改善患者生活质量。 Objective: To observe the clinical efficacy of Xiaoyao Wuling San( 逍遥五苓散) plus trimebutine maleate capsule on IBS of diarrhea type. Methods: 80 patients were randomly divided into the treatment group of 44 cases and control group of 36 cases. The control group was given the trimebutine maleate capsule, 0.2 g a time, 3 times daily, 30 minutes before meals, orally. The treatment group was given Xiaoyao Wuling San more, a dose for two days after meals. The score of TCM symptoms(abdominal pain, number of diarrhea, stool shape, mucus) and clinical efficacy in two groups were compared before and after 4 course. Results: The total efficiency in the treatment group and control group was 95.45% and 86.11% respectively, with a statistically significant difference, P〈0.05. Conclusion: Xiaoyao Wuling San plus trimebutine maleate capsule on IBS of diarrhea type can improve clinical efficacy and life quality.
作者 闫旭明
出处 《中医临床研究》 2018年第10期89-90,共2页 Clinical Journal Of Chinese Medicine
关键词 肠易激综合征 腹泻 逍遥五苓散 马来酸曲美布汀 Irritable bowel syndrome Diarrhea Xiaoyao Wuling San Trimebutine maleate
  • 相关文献

参考文献3

二级参考文献25

  • 1陈治水,张万岱,危北海.肠易激综合征中西医结合诊治方案(草案)[J].中国中西医结合杂志,2005,25(3):282-284. 被引量:137
  • 2Douglas A.Drossman,蒋晓玲(译),萧树东(校).罗马Ⅲ:新的标准[J].胃肠病学,2006,11(12):705-707. 被引量:513
  • 3刘新光.肠易激综合征的药物治疗[J].现代消化及介入诊疗,2007,12(2):102-105. 被引量:15
  • 4张文静.成人肠易激综合征诊治新指南[J].现代消化及介入诊疗,2007,12(2):141-141. 被引量:32
  • 5中华中医药学会.中医内科常见病诊疗指南.西医疾病部分[M].北京:中国中医药出版社,2008.
  • 6Delvaux M, Wingate D. Trimebutine: mechanismof action, effects on gastrointestinal function and clinical results. J Int Med Res, 1997, 25: 225~246.
  • 7Simon EJ. Opioid receptors and endogenous opi-oid peptides. Med Res Rev, 1991, 11: 357~374.
  • 8Schang JC, Devroede G, Pilote M. Beneficial effects of trimebutine in patients suffering from irritable bowel disease with normal transit and constipation. Gastroenterology, 1988, 94: A403.
  • 9Luttecke K. A three-part controlled study of trimebutine in the treatment of irritable colon syndrome. Curr Med Res Opin, 1980, 6: 437~443.
  • 10Drossman DA.Psychosocial and psychophysiologic mechanisms in GI Ⅲ ness.In:Kirsner JB,ed.The growth of gastroenterologic knowledge in the 20th century.Philadelphia:Lea & Febiger; 1993.41~432.

共引文献528

同被引文献94

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部